tosufloxacin has been researched along with Bronchitis in 2 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
Excerpt | Relevance | Reference |
---|---|---|
"A 14-year-old girl was treated for 3 days with tosufloxacin (450 mg twice a day) for acute bronchitis and then developed acute kidney injury." | 3.83 | Crystalline nephropathy caused by tosufloxacin. ( Kibe, T; Matsubara, R; Nomura, T, 2016) |
"A 74-year-old man had been given tosufloxacin tosilate for the treatment of acute bronchitis on December 6,1996." | 3.70 | [Drug-induced pneumonitis with eosinophilic infiltration due to tosufloxacin tosilate]. ( Abe, Y; Kimura, N; Matsuno, O; Miyazaki, E; Tsuda, T, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsubara, R | 1 |
Kibe, T | 1 |
Nomura, T | 1 |
Kimura, N | 1 |
Miyazaki, E | 1 |
Matsuno, O | 1 |
Abe, Y | 1 |
Tsuda, T | 1 |
2 other studies available for tosufloxacin and Bronchitis
Article | Year |
---|---|
Crystalline nephropathy caused by tosufloxacin.
Topics: Acute Kidney Injury; Adolescent; Biopsy; Bronchitis; Diagnosis, Differential; Female; Fluoroquinolon | 2016 |
[Drug-induced pneumonitis with eosinophilic infiltration due to tosufloxacin tosilate].
Topics: Aged; Anti-Infective Agents; Bronchitis; Drug Hypersensitivity; Eosinophils; Fluoroquinolones; Human | 1998 |